These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12479704)

  • 1. Identification of combination gene sets for glioma classification.
    Kim S; Dougherty ER; Shmulevich I; Hess KR; Hamilton SR; Trent JM; Fuller GN; Zhang W
    Mol Cancer Ther; 2002 Nov; 1(13):1229-36. PubMed ID: 12479704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
    Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
    Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
    Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
    Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype.
    Xu X; Joh HD; Pin S; Schiller NI; Prange C; Burger PC; Schiller MR
    Cancer Lett; 2001 Sep; 171(1):67-77. PubMed ID: 11485829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.
    Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME
    Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biology.
    Wuchty S; Zhang A; Walling J; Ahn S; Li A; Quezado M; Oberholtzer C; Zenklusen JC; Fine HA
    J Biomed Inform; 2010 Dec; 43(6):945-52. PubMed ID: 20828632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.
    Zhang CB; Zhu P; Yang P; Cai JQ; Wang ZL; Li QB; Bao ZS; Zhang W; Jiang T
    Oncotarget; 2015 Nov; 6(34):36643-51. PubMed ID: 26436699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification of gliomas. Current progress and perspectives].
    Capper D; Reifenberger G
    Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling identifies molecular subtypes of gliomas.
    Shai R; Shi T; Kremen TJ; Horvath S; Liau LM; Cloughesy TF; Mischel PS; Nelson SF
    Oncogene; 2003 Jul; 22(31):4918-23. PubMed ID: 12894235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREDICTING SIGNIFICANCE OF UNKNOWN VARIANTS IN GLIAL TUMORS THROUGH SUB-CLASS ENRICHMENT.
    Fichtenholtz AM; Camarda ND; Neumann EK
    Pac Symp Biocomput; 2016; 21():297-308. PubMed ID: 26776195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.
    Fuller GN; Rhee CH; Hess KR; Caskey LS; Wang R; Bruner JM; Yung WK; Zhang W
    Cancer Res; 1999 Sep; 59(17):4228-32. PubMed ID: 10485462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
    Persson O; Krogh M; Saal LH; Englund E; Liu J; Parsons R; Mandahl N; Borg A; Widegren B; Salford LG
    J Neurooncol; 2007 Oct; 85(1):11-24. PubMed ID: 17634744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
    Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes.
    Li A; Walling J; Ahn S; Kotliarov Y; Su Q; Quezado M; Oberholtzer JC; Park J; Zenklusen JC; Fine HA
    Cancer Res; 2009 Mar; 69(5):2091-9. PubMed ID: 19244127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.
    Caskey LS; Fuller GN; Bruner JM; Yung WK; Sawaya RE; Holland EC; Zhang W
    Histol Histopathol; 2000 Jul; 15(3):971-81. PubMed ID: 10963139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy.
    Vitucci M; Hayes DN; Miller CR
    Br J Cancer; 2011 Feb; 104(4):545-53. PubMed ID: 21119666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.